Success Story: NIW Approved For an Iranian PhD Candidate - Graduate Assistant With Our Assistance
Client’s Testimonial:
“Thank you so much for your help and support throughout my NIW petition process. I truly appreciate your excellent work and professionalism. I’m very glad I made the right decision to start this process with your team. I would also like to thank you for your flexibility with the payment schedule when I needed to adjust it during a tight budget period.”
On September 29th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate – Graduate Assistant in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: PhD Candidate – Graduate Assistant
Country of Origin: Iran
State of Residence at the Time of Filing: New York
Approval Notice Date: September 29th, 2025
Processing Time: 6 months, 17 days
Case Summary:
The client – a distinguished expert in the field of immunology – entrusted North America Immigration Law Group with the preparation of a National Interest Waiver (NIW) petition under the EB-2 category, a process that ultimately led to a successful approval.
At North America Immigration Law Group, our experience handling complex petitions has allowed us to consistently secure favorable outcomes for researchers at the forefront of their disciplines. For this case, we highlighted the client’s unique expertise and clearly demonstrated how the proposed endeavor aligned with both national health priorities and the advancement of biomedical science.
We emphasized several key qualifications to make the case compelling. The client is a highly skilled immunologist whose work focuses on investigating the molecular mechanisms that regulate immune responses and inflammation. Specifically, the research centers on the regulation of CD47 through Rab4A and its role in systemic lupus erythematosus, with the goal of developing targeted therapies that modulate immune responses without compromising cancer immunity. This line of study directly supports the creation of safer, more effective treatment options for patients with autoimmune conditions – a matter of national importance given the growing prevalence of these diseases in the U.S.
The client has authored 11 peer-reviewed journal articles (including 1 first-authored paper) that have collectively garnered 242 citations, reflecting the widespread use and influence of this research among peers in the global immunology community. Moreover, several of the client’s studies have appeared in top-ranked journals, publications recognized for their high impact and rigorous review standards.
We also underscored that the client’s work has received support from the National Institutes of Health (NIH), one of the most competitive and prestigious funding agencies in the biomedical sciences. This recognition further validated the importance of the client’s contributions to advancing U.S. research objectives in immunology and disease treatment.
Thanks to our team’s thorough preparation and strategic presentation of evidence, USCIS approved the petition, recognizing that the client’s continued research would significantly benefit the United States by addressing urgent needs in immune-related disorders and therapeutic innovation.
We are honored to have guided this accomplished researcher through the NIW process and proud to celebrate another successful outcome.